Members

Kevin Doe's Blog (244)

The teleradiology services market is projected to grow at a CAGR of 16.8% till 2030, claims Roots Analysis

Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” report to its list of offerings.

Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Such services enable hospitals / diagnostic centers to manage heavy workload, while maintaining high report quality with lower discrepancies and better reporting efficiency. Following the onset of COVID-19 pandemic,…

Continue

Added by Kevin Doe on February 5, 2022 at 3:20pm — No Comments

The teleradiology services market is projected to grow at a CAGR of 16.8% till 2030, claims Roots Analysis

Roots Analysis has announced the addition of “Teleradiology Services Market, 2021-2030” market report to its list of offerings.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these services over the next decade. The report features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:

 A detailed assessment…

Continue

Added by Kevin Doe on February 5, 2022 at 3:19pm — No Comments

The HUMIRA® biosimilars market is projected to witness considerable growth over the coming years

Roots Analysis has announced the addition of the “HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.

Being one of the first biologics against anti-inflammatory diseases, HUMIRA® is considered an aberration in terms of patent protection, with AbbVie strategically covering novel uses of the product and thereby, enjoys uncharacteristically prolonged marketing exclusivity. In fact, a year after multiple adalimumab biosimilars were…

Continue

Added by Kevin Doe on February 3, 2022 at 11:43am — No Comments

The Fc protein and glyco-engineered antibodies market

London

Roots Analysis has announced the addition of “Fc Protein and Glyco-engineered Antibodies Market, 2021-2030” report to its list of offerings.

Over time, a substantial body of evidence has validated the therapeutic applications of Fc engineering platforms; Fc modified antibodies have shown to augment the various immune effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), antibody-dependent cellular…

Continue

Added by Kevin Doe on February 2, 2022 at 1:12pm — No Comments

DNA DAMAGE RESPONSE TARGETING THERAPEUTICS (BEYOND PARP INHIBITORS) - CURRENT MARKET LANDSCAPE

During our research, we came across over 43 companies that are presently engaged in the development of DDR targeting therapeutics. There has been a significant increase in the number of developers that have been established in this domain post-2008. In fact, close to XX players were established during the period 2013-2016. Further, over XX developers have been founded since 2017.

To order this 130+ slides report, which features 80+ figures, please visit…

Continue

Added by Kevin Doe on January 31, 2022 at 11:30am — No Comments

The bioprocess controllers and automation systems market

Roots Analysis has announced the addition of “Bioprocess Controllers and Automation Systems Market, 2021-2030” report to its list of offerings.

The bioprocess controllers and automation systems have turned out to be a process optimization solution for the biopharmaceutical industries, overcoming the inadequacies of the traditional bioreactor systems. Amidst the COVID-19 pandemic, the increasing demand for biologics has led to the surge in the adoption rate of the aforementioned…

Continue

Added by Kevin Doe on January 31, 2022 at 11:25am — No Comments

The on-body drug delivery-related intellectual landscape report

Several innovative drug delivery technologies have gathered notable momentum (in terms of adoption and sales) soon after entering the market; most of these are designed to address the unmet needs of administering complex pharmacological interventions

Roots Analysis has announced the addition of the “On-body Drug Delivery Devices - Intellectual Property Landscape: Focus on Popular / Relevant Prior Art Search Expressions, Patent Valuation, Pockets of Innovation / White Spaces, and Key…

Continue

Added by Kevin Doe on January 27, 2022 at 11:29am — No Comments

The Market is Expected to Grow at an Annualized Rate of ~30% Over the Coming Decade

Stringent regulatory guidelines pertaining to cell and gene therapies has made it mandatory for developer companies to conduct extensive preclinical and clinical research to generate the necessary body of evidence, validating the safety, efficacy and benefits of their proprietary products. As a consequence, capital investments required in R&D have increased substantially. It is worth highlighting that even the well-established players in the industry are gradually opting to outsource…

Continue

Added by Kevin Doe on January 27, 2022 at 11:23am — No Comments

The modular facility manufacturing market is projected to grow at an annualized rate of ~8.8%, till 2030

To order this 300+ page report, which features 120+ figures and 130+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/modular-facilities-flexible-drug-manufacturing-platforms-of-the-future/178.html

Key Market Insights

 30+ companies offer services for the construction of modular facilities; a relatively…

Continue

Added by Kevin Doe on January 25, 2022 at 6:25am — No Comments

The modular facilities market is estimated tobe worth USD 6.4 billion in 2030, predicts Roots Analysis

Roots Analysis is pleased to announce the publication of its recent study, titled, “Modular Facilities in Pharmaceutical and Biotechnology Market”

The report features an extensive study of the current market landscape and future potential of the players engaged in offering services for modular facility construction for biotechnology and pharmaceutical industries. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.…

Continue

Added by Kevin Doe on January 25, 2022 at 6:22am — No Comments

The “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030”

Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”

Key Inclusions

 A review of the current market landscape of companies offering pharmaceutical contract manufacturing services in China, along with information on year of establishment, company size, location of headquarters, type of product (active pharmaceutical ingredients (APIs), intermediates and finished dosage…

Continue

Added by Kevin Doe on January 23, 2022 at 12:33pm — No Comments

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

Roots Analysis is pleased to announce the publication of its recent study, titled, “RNAi Therapeutics Market (2nd Edition), 2019-2030.”

The “RNAi Therapeutics Market (2nd Edition), 2019-2030: Focus On siRNA, miRNA, shRNA and DNA” report features an extensive study of the current market landscape and future opportunities associated with RNAi therapeutics. The study also features a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the…

Continue

Added by Kevin Doe on January 23, 2022 at 12:32pm — No Comments

IN PURSUIT OF A COMPETITIVE EDGE, STAKEHOLDERS ARE ACTIVELY EXPANDING THEIR EXISTING CAPABILITIES

The primary purpose of this analysis was to develop a deeper understanding of the overall strength of the contract service providers involved in this field. It allows companies to compare their existing capabilities within their respective peer groups and identify ways to gain a competitive edge in the industry. In addition, this analysis can be used by the companies to ascertain improvement areas by identifying the gaps between their existing capabilities and the best available practices in…

Continue

Added by Kevin Doe on January 19, 2022 at 2:08pm — No Comments

Continuous Manufacturing Market by Roots Analysis

To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html

Key Inclusions

 A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of…

Continue

Added by Kevin Doe on January 15, 2022 at 6:00am — No Comments

TIL-based Therapies Market by Roots Analysis

Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.

The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

 A detailed assessment of the current…

Continue

Added by Kevin Doe on January 15, 2022 at 5:59am — No Comments

CAR-T Cell Therapies Market (3rd Edition)

Roots Analysis has announced the addition of “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World) – Industry Trends and…

Continue

Added by Kevin Doe on January 15, 2022 at 5:58am — No Comments

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition) by Roots Analysis

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, autoinjectors, needle-free injectors and large volume wearable injectors, have been / are being designed for subcutaneous administration of biologics.

To order this 530+ page report, which features 160+ figures and 190+ tables,…

Continue

Added by Kevin Doe on January 10, 2022 at 6:23am — No Comments

NOVEL OCULAR DRUG DELIVERY DEVICES MARKET: PATENT ACTIVITY TO ACCELERATE INNOVATION

Over 1,110 patents related to novel ocular drug delivery devices have been filed / granted in the past few years, indicating the enhanced pace of innovation in this field.

To order this detailed 180+ page report, please visit this - https://www.rootsanalysis.com/reports/novel-ocular-drug-delivery-devices-market.html

Over 90% of the patents related to ocular drug delivery devices…

Continue

Added by Kevin Doe on January 10, 2022 at 6:23am — No Comments

Novel Drug Reconstitution Systems Market, 2021-2030

In 2018, seven out of ten top-selling prescription medicines were biologics. The liquid formulations of biologics are not much stable and tend to lose efficacy with time due to the changes in their pharmacokinetic and pharmacodynamic properties. Therefore, lyophilization of such drugs is essential before their storage. Around 50% of the biologics intended for parenteral administration are available in lyophilized form, which require reconstitution before administration.

To Request for…

Continue

Added by Kevin Doe on January 10, 2022 at 6:22am — No Comments

CAR-T Cell Therapies Market (3rd Edition) by Target Indications by Roots Analysis

Roots Analysis is pleased to announce the publication of its recent study, titled, “CAR-T Cell Therapies Market (3rd Edition) by Target Indications (NHL, Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Hepatocellular Carcinoma and Others), Target Antigens (CD19, BCMA, CD19 / CD22, GPC3 and EGFR), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest…

Continue

Added by Kevin Doe on January 6, 2022 at 5:11pm — No Comments

Monthly Archives

2022

2021

© 2022   Created by PH the vintage.   Powered by

Badges  |  Report an Issue  |  Terms of Service